Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L E van Bork

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|March 27, 1976
Bioavailability after intramuscular injectionJ H Jonkman, L E van Bork, R A de Zeeuw, et al.
Clinical Pharmacology and Therapeutics|April 1, 1977
Variations in the bioavailability of thiazinamium methylsulfateJ H Jonkman, L E Van Bork, J Wijsbeek, et al.
Pharmaceutisch Weekblad. Scientific Edition|October 22, 1982
Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. II. Oral and rectal administrationJ H Jonkman, J Wijsbeek, R A De Zeeuw, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Pharmacokinetics and pharmacodynamics of thiazinamium in asthmatic patientsN H Holford, P Clements, P Collier, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 23, 1977
[Diagnostic and therapeutic use of thiazinamium (Multergan)]L E van Bork, J H Jonkman, R A de Zeeuw, et al.
Journal of Chromatography|November 11, 1977
Determination of oxyphenonium bromide in plasma and urine by means of ion-pair extraction, derivatization and gas chromatography-electron-capture detectionJ E Greving, J H Jonkman, F Fiks, et al.
The Journal of Pharmacy and Pharmacology|December 1, 1976
"First pass effect" after rectal administration of thiazinamium methylsulphate [proceedings]J H Jonkman, L E van Bork, J Wijsbeek, et al.
Pharmaceutisch Weekblad. Scientific Edition|October 22, 1982
Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. I. Parenteral administrationJ H Jonkman, J Wijsbeek, R A De Zeeuw, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|September 1, 1983
Clinical pharmacokinetics of intramuscular thiazinamium methyl sulfateJ H Jonkman, L E Van Bork, B Calvert, et al.
European Journal of Respiratory Diseases. Supplement|January 1, 1984
Relationship between plasma concentration and the pulmonary and cardiac effects of three anticholinergicsL E van Bork, J H Jonkman, J E Greving, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|March 27, 1976
Bioavailability after intramuscular injectionJ H Jonkman, L E van Bork, R A de Zeeuw, et al.
Clinical Pharmacology and Therapeutics|April 1, 1977
Variations in the bioavailability of thiazinamium methylsulfateJ H Jonkman, L E Van Bork, J Wijsbeek, et al.
Pharmaceutisch Weekblad. Scientific Edition|October 22, 1982
Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. II. Oral and rectal administrationJ H Jonkman, J Wijsbeek, R A De Zeeuw, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Pharmacokinetics and pharmacodynamics of thiazinamium in asthmatic patientsN H Holford, P Clements, P Collier, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 23, 1977
[Diagnostic and therapeutic use of thiazinamium (Multergan)]L E van Bork, J H Jonkman, R A de Zeeuw, et al.
Journal of Chromatography|November 11, 1977
Determination of oxyphenonium bromide in plasma and urine by means of ion-pair extraction, derivatization and gas chromatography-electron-capture detectionJ E Greving, J H Jonkman, F Fiks, et al.
The Journal of Pharmacy and Pharmacology|December 1, 1976
"First pass effect" after rectal administration of thiazinamium methylsulphate [proceedings]J H Jonkman, L E van Bork, J Wijsbeek, et al.
Pharmaceutisch Weekblad. Scientific Edition|October 22, 1982
Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. I. Parenteral administrationJ H Jonkman, J Wijsbeek, R A De Zeeuw, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|September 1, 1983
Clinical pharmacokinetics of intramuscular thiazinamium methyl sulfateJ H Jonkman, L E Van Bork, B Calvert, et al.
European Journal of Respiratory Diseases. Supplement|January 1, 1984
Relationship between plasma concentration and the pulmonary and cardiac effects of three anticholinergicsL E van Bork, J H Jonkman, J E Greving, et al.
Pageof 2